Young person and adult screening KPI data: Q1 summary factsheets
Updated 10 October 2024
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/nhs-screening-programmes-kpi-reports-2020-to-2021/young-person-and-adult-screening-quarter-1-kpi-data-summary-factsheets
Please be aware that this data covers the time period through the COVID-19 pandemic. Provider performance should therefore be interpreted with caution.
In addition to this, some providers were justifiably not able to make timely data returns or validate their data in this period. We recommend looking at the historical trend data of services before the COVID-19 pandemic to help interpret the data.
1. Abdominal aortic aneurysm screening
1.1 KPI AA2: coverage: initial screen
National performance of AA2 up to 31 March 2020 is shown in the trend graph below. AA2 is an annual indicator and quarterly figures are cumulative from Q1 to Q4.
Publication of regional and provider level data for AA2 has been withdrawn for Q1 due to impact of the COVID-19 pandemic on screening activity that occurred during this time period.
Quarter 1 performance
| Reporting period | 1 April to 30 June 2020 |
|---|---|
| Numerator | 26,647 |
| Denominator | 301,149 |
| Performance | Withdrawn |
| Completeness of data | Withdrawn |
1.2 KPI AA3: coverage: annual surveillance scan
National performance of AA3 up to 31 March 2020 (Q4) is shown in the trend graph below.
Publication of this KPI has been withdrawn for Q1 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services in this period.
1.3 KPI AA4: coverage: quarterly surveillance scan
National performance of AA4 up to 31 March 2020 (Q4) is shown in the trend graph below.
Publication of this KPI has been withdrawn for Q1 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services in this period.
2. Diabetic eye screening
2.1 KPI DE1: uptake: routine digital screening
National performance of DE1 in Q1 was 76.3%. The national trend graph below shows that DE1 performance has remained above the acceptable threshold of 75% since 1 April 2017. All 58 screening services submitted data. DE1 is an annual rolling figure.
Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted and overall numbers will be smaller. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 1 performance
| Reporting period | 1 April to 30 June 2020 |
|---|---|
| Numerator | 1,680,891 |
| Denominator | 2,202,988 |
| Performance | 76.3% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 80.3% |
| Midlands and East | 73.9% |
| North | 75.0% |
| South | 79.3% |
| England | 76.3% |
2.2 KPI DE2: test: timeliness of results letters
National performance of DE2 in Q1 was 96.5%. The national trend graph below shows that DE2 performance has remained above the achievable threshold of 95% since 1 October 2018. All 58 screening services submitted data.
Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted and overall numbers will be smaller. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 1 performance
| Reporting period | 1 April to 30 June 2020 |
|---|---|
| Numerator | 19,524 |
| Denominator | 20,242 |
| Performance | 96.5% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 99.1% |
| Midlands and East | 98.3% |
| North | 93.9% |
| South | 95.8% |
| England | 96.5% |
2.3 KPI DE3: intervention/treatment: timely consultation for people with diabetes who are screen positive
National performance of DE3 in Q1 was 73.2%. The national trend graph below shows that DE3 performance has remained below the acceptable threshold of 80% since 1 April 2017. All 58 screening services submitted data.
Due to the ongoing coronavirus response and restoration of screening this KPI may be impacted and overall numbers will be smaller. Local services should highlight this with their commissioners where they consider that this KPI has been impacted by the COVID-19 response.
Quarter 1 performance
| Reporting period | 1 April to 30 June 2020 |
|---|---|
| Numerator | 576 |
| Denominator | 787 |
| Performance | 73.2 |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 72.6% |
| Midlands and East | 78.5% |
| North | 70.9% |
| South | 71.9% |
| England | 73.2% |
3. Bowel cancer screening
3.1 KPI BCS1: uptake
National performance of BCS1 up to 31 March 2020 (Q4) is shown in the trend graph below.
Publication of regional and provider level data for BCS1 has been withdrawn for Q1 due to impact of the COVID-19 pandemic on screening activity that occurred during this time period. This resulted in a high number of providers reporting less than 5 individuals invited in the reporting period.
Quarter 1 performance
| Reporting period | 1 April to 30 June 2020 |
|---|---|
| Numerator | 253 |
| Denominator | 604 |
| Performance | Withdrawn |
| Completeness of data | Withdrawn |
3.2 KPI BCS2: coverage
National performance of BCS2 in Q4 2019 to 2020 was 63.8%, the highest ever level published for this KPI. BCS2 is available 6 months (2 quarters) in arrears. The national trend graph below shows BCS2 performance since 1 April 2017. There are no thresholds set for this KPI.
Coverage ranged from 56.2% in London to 66.3% in the South.
Quarter 4 performance
| Reporting period | 1 January to 31 March 2020 |
|---|---|
| Numerator | 5,246,042 |
| Denominator | 8,218,982 |
| Performance | 63.8% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 56.2% |
| Midlands and East | 64.0% |
| North | 64.4% |
| South | 66.3% |
| England | 63.8% |
4. Breast screening
4.1 KPI BS1: uptake
National performance of BS1 up to 31 March 2020 (Q4) is shown in the trend graph below.
Publication of this KPI has been withdrawn for Q1 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services in this period.
4.2 KPI BS2: uptake: screening round length
National performance of BS2 up to 31 March 2020 (Q4) is shown in the trend graph below.
Publication of this KPI has been withdrawn for Q1 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services in this period.
5. Cervical screening
5.1 KPI CS1: coverage under 50 years
National performance of CS1 in Q1 was 69.4%. The national trend graph below shows that CS1 performance has remained below the acceptable threshold of 80% since 1 April 2017.
None of the 135 CCGs met the acceptable threshold
Quarter 1 performance
| Reporting period | 1 April to 30 June 2020 |
|---|---|
| Numerator | 7,094,685 |
| Denominator | 10,229,244 |
| Performance | 69.4% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 61.0% |
| Midlands and East | 71.1% |
| North | 72.0% |
| South | 71.9% |
| England | 69.4% |
5.2 KPI CS2: coverage 50 years and above
National performance of CS2 in Q1 was 75.8%. The national trend graph below shows that CS2 performance has remained below the acceptable threshold of 80% since 1 April 2017.
One CCG out of 135 met the acceptable threshold.
Quarter 1 performance
| Reporting period | 1 April to 30 June 2020 |
|---|---|
| Numerator | 3,867,731 |
| Denominator | 5,101,775 |
| Performance | 75.8% |
| Completeness of data | 100% |
| Region | Performance % |
|---|---|
| London | 72.9% |
| Midlands and East | 76.5% |
| North | 76.2% |
| South | 76.3% |
| England | 75.8% |